Doctors Without Borders has estimated that up to 80 percent of meningitis patients may die without early access to treatment.This statement comes as the organization warns that meningitis—particularly ...

was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11–55 years. The first meningococcal vaccine ...